                </a></li></ul></div><p><strong>Figure 2.  <span>CTL activities derived from cell cultures of 4 HIV-infected individuals (I, II, III and IV) directed against autologous target-cells presenting cA1 peptide, control B1 peptide, or target-cells infected with either wild type vaccinia virus or recombinant vaccinia virus expressing gp160MN.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>The CTL cultures were generated by polyclonal activation with the irradiated autologous cells. After a 10 day incubation the effector cells were tested for CTL activity as described in <a href="#s2">materials and methods</a>. The data are representative of 3 independent experiments performed in triplicates. Standard errors of the mean (s.e.m) from triplicate wells were 5% of the mean.</p>
